Submission Preparation ChecklistAs part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
- The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
- The submission file is in OpenOffice, Microsoft Word, or RTF document file format.
- Where available, URLs for the references have been provided.
- The text is single-spaced; uses a 12-point font; employs italics, rather than underlining (except with URL addresses); and all illustrations, figures, and tables are placed within the text at the appropriate points, rather than at the end.
- The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines.
The Submitted Manuscript should follow the below :
- Having innovative and creative outcome.
- Methods should preferably be advanced and reproducible.
- manuscripts should written in Britih English.
Types of Manuscripts
These include randomized controlled trials, intervention studies, studies of screening and diagnostic test, outcome studies, and cost-effectiveness analyses. The text of original articles amounting to utmost 3000 words (excluding Abstract, References and Tables) should include Title; the AbÂstract; Introduction; MaÂterials & Methods; Results; Discussion; Conclusion; AcÂknowlÂedgeÂment; RefÂerences, Tables and Figures (Not more than 4500 words).
They should be written by authors considered experts on the subject. Therefore, the corresponding author of the review article must be one of the authors of at least three articles presented in Reference section. Systematic reviews and meta-analysis are more welcomed and they should respectively follow the PRISMA (http://www.prisma-statement.org/) and MOOSE guidelines (http://www.consort-statement.org). Review articles must include an abstract of no more than 300 words, a main text between 2000-3000 words excluding up to 90 references, and up to 6 tables and/or figures (altogether 5500-6000 words).
Short communications are brief reports of research works containing new findings, which are not exceeding 2500 words from introduction through references. The Short Communication consists of Abstract, main body including Introduction, Methods, Results, Discussion, Conclusion; Acknowledgement, References, Tables and Figures (Not more than 3000 words).
Case reports are accepted provided they are of exceptional interest for readers. The case report consists of Abstract (unstructured), Introduction, Case Report, Discussion, Acknowledgements, and References. Case reports must not exceed 1,000 words, 15 references and a reasonable amount of tables and/or figures (Not more than 2500 words).
Letters to the Editor:
Letters could be of two types, commenting either on recently published articles or reporting cases, outbreaks, or original research. The former must be received within 2 months of publication of the article to which they refer and should be no longer than 500 words. The latter should contain no more than 1000 words altogether including up to 10 references and 2 figures and/or tables. They should not be divided into sections.
Guest Editorial is solicited by the Editorial Board.
Submission Preparation guideline:
The title page should carry the following:
Concise but informative title of the article. Chemical formulas or abbreviations should not be used, but long common terms such as names of compounds or enzymes can be abbreviated.
All author's full names without academic degrees.
Full names of the department(s) and institution(s) in which the research was done, together with the location (city, state, and nation). If the article has several authors from different institutions, it should be clearly indicated with which department and institution each author is affiliated using superscript numbers.
Key words, limited to five words or short phrases, taken from Index Medicus [Medical Subject Heading - MeSH] or composed by analogy on the same principles.
A brief running head, not to exceed 60 characters (count letters and spaces). Abbreviations defined in the text can be used.
Corresponding author's name, full address, telephone and fax numbers, and e-mail address.
Not exceed 300 words (approximately 1 page of A4) in length.
State the purpose of the investigation, then describe the study design or experimental procedure, main findings or major contributions, and finally the specific conclusion or recommendation, in a 4 paragraphs with specific ( Objective, Methods, Results, Conclusion ) subheadings.
Provide enough information for the Abstract to be easily understood without reference to the text, and emphasize new and important aspects of the study.
Avoid nonstandard abbreviations, unfamiliar terms or symbols, and laboratory jargon. Abbreviations should be kept to an absolute minimum; but if necessary, they must be spelled out at first mention. Standard metric units (mm, cm, ml, l, mg, g, msec, sec, min, hr, etc.) can be used throughout without definition.
Structure of Original/Research Articles:
Give concise background information relevant to the study and the questions the study seeks to answer. The readers should be able to understand why the study was done.
Materials and Methods:
Describe subjects, materials, and methods used, including experimental design or procedures, in sufficient detail to enable the readers to evaluate and/or reproduce the results. Subjects should be described appropriately to show that the control and experimental groups contained matched subjects
Designate drugs by their generic names; but for particular chemicals or equipment, the brand names and locations of the supplier (city, state, and nation) should be given in parentheses.
Describe statistical methods and details of randomization or blinded observations. Specify the numbers of observations made and individuals who could not be followed up until the end of the study.
Protect patient anonymity by avoiding details that might identify patients unless essential for scientific purposes. Masking of the eye region in photographs of patients may be inadequate. If identification of patients is unavoidable, written permission should be obtained.
Include only the data and illustrative materials that are pertinent to the subject of the article.
Avoid repetition of all the data in the tables or illustrations in the text, but do emphasize or summarize important trends or observations.
Avoid duplicate presentation of the same data in both tabular and graphic forms.
Interpret the present data concisely, giving particular attention to the question or hypothesis posed in the Introduction section. Information presented in the previous sections should not be repeated.
Include discussion of previous works that not only agree but also disagree with the present results.
State the conclusions or recommendations that can be directly drawn from the present results. Logical implications of the present findings for practical applications or future studies are permissible, but unsubstantiated speculations must not be included.
State personal or institutional contributions, and financial or material support. Supply full information for nature of support (technical help, critical review, data collection, and participation in clinical trial), number of grants-in-aid, and name and location of institution or organization.
Conflicts of Interest Disclosure:
All authors must state any actual or potential conflicts of interest with regard to the manuscript submitted for review under a heading of Conflicts of Interest (COI) Disclosure following the Acknowledgment section. Authors should also state if there are no conflicts of interest.
Number references consecutively in the order cited in the text, not alphabetically. If no person or organization can be identified as the author and no editors or translators are given, begin the reference with the title of the article..
All the references should be cited in the article as superscript numbers . Papers accepted but not yet published can be included in the reference list, but papers in preparation, unpublished observations, and personal communication should be noted in parentheses in the text.
Follow Vancover style.
Note: The journal advice author(s) to use Endnote for manage their refrences.
Cite all figures in the text, and number consecutively in the order cited in the text.
Titles and detailed explanations should be given in the legends, not on the figures. All abbreviations used in each figure should be explained in each legend.
Figure legends should provide a brief, self-sufficient explanation of the illustrations. Describe the staining method and original magnification for photomicrographs, and bar measurements for electron micrographs.
If a figure has already been published, obtain permission to reproduce or modify from the copyright holder, and acknowledge the original source in the legend.
Cite all tables in the text, and number consecutively according to appearance in the text.
Type each table on a separate page, supplying a brief title and explanatory footnotes. All abbreviations used in each table should be explained in the footnotes.
Each column must carry an appropriate heading, and units in numerical measurements should be added to the column heading in parentheses.
If data can be described in one or two sentences in the text, do not present them in a table.
Randomized Controlled Trial Registry:
Reports of randomized clinical trials should present information on all major study elements, including the protocol, assignment of interventions (methods allocation to treatment groups), and the method of masking (blinding), based on the CONSORT Statement (http://www.consort-statement.org). Authors should describe the registration number at the end of the abstract and in the session of Materials and Methods of the text. Registration in one of the WHO ICRTP trials registers network is acceptable :
in addition to:
Experimental studies on animals must include a statement that the studies meet appropriate ethical standards of the responsible committee. The authors should state in the text whether the procedures followed in experiments on human subjects were conducted in accordance with the ethical standards of the responsible committee on human experimentation (institutional or regional review board) or with the Declaration of Helsinki 1964, and its later amendments. The authors should also obtain written informed consent from subject included in the study, and state such information in the text. A PDF of the statement of approval of the study by institutional or regional review board should be attached. Details in the text, figures, photographs that might disclose identity of subjects should be omitted to preserve subjects anonymity. The Editors reserve the right to reject manuscripts that do not comply with the Journal ethical standards. The authors are responsible when any faulty statement is disclosed.
Protection of Patients' Rights to Privacy
Informed consent from the participants and from the parents or legal guardians of minors should be taken and stated in the study under the Materials and Method section.
Authors should remove patients' names from figures. Any data leading to direct patient identification, strictly should be omitted.
IMJ follow COPE's its Best Practice Guidelines for Journal Editors. Plagiarism of text from a previously published manuscript by the same or another author is a serious publication offence. Small amounts of text may be used, but only where the source of the material quoted is clearly acknowledged and the text is inserted in quotation mark. If there is an allegation of plagiarism, scientific misconduct or fraud, IMJ will follow the recommendations of the COPE and ICMJE. IMJ will put the author(s) in its blacklist and will not accept any other submission from that author(s) for at least 2 years for all Nab'a Al-Hayat foundation journals. The Journal reserves the right to report the allegations to the author's institution or any other agency.
Conflicts of Interest (COI):
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence their work. Examples of potential conflicts of interest include employment consultancy relationship, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding, etc.
Peer review process:
Iraq Medical Journal is a double-blind peer-reviewed journal. All manuscripts will be acknowledged upon presenting to the Journal office, if all stated requirements are met. According to the policy of peer review in our Journal, a large extent of manuscripts are rejected through an in-house evaluation process based on a category of criteria including over flow of manuscripts, out of scope cases, poor outcome, local studies, clinical contents etc.
This process takes no more than two weeks and the author(s) will be informed of the primary decision. The first stage passed manuscripts are sent to two or three reviewers. The whole review process depends on receiving referees' comments and revising the manuscripts based on these comments to the author. On receipt of the revised article from the author, and after final approving by referees, the letter of acceptance is issued to the corresponding author only. Due to plenty of papers waiting for publishing, the article takes more than 6 months for publication. Authors have the right to communicate to the editor if they do not wish their manuscript to be reviewed by a particular reviewer because of potential conflicts of interest. The author can also suggest the name of possible competent reviewers but it is up to the editor to accept it. No article is rejected unless negative comments are received from at least two reviewers.
To assist the speed of peer review process, authors are requested to introduce four well-known experts with their contact details, but the Editor-in-Chief would be emancipated finally.
The revised version of the manuscript should be included with reply to referee comments separately article to article. In addition, the changes should be marked as underlined or colored text in the article.
Authors are sent galley proofs for checking the production after acceptance of the article. Proofs are sent by e-mail as Word files and considering that the Journal is published monthly, if for any reason, after 2 days, the Journal does not receive any reply, we consider the manuscript approved, and no changes will be acceptable after that. It is the authors responsibility to check that all the text and data as contained in the page proofs are correct and suitable for publication. We request that authors pay particular attention to author's names and affiliations, as it is essential that these details are accurate when the article is published. In this step, the authors absolutely, cannot add any authors or large sentences to the article, besides; they are not allowed to change the corresponding author.
After approving the galley proof, no changes would be accepted and the responsibility would be on author(s) side.
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.
If due to unethical practices the journal has to retract an article, the author is responsible for all potential costs of updating the indexing databases.
Correspondence concerning editorial problems should be addressed to: